Artificial intelligence (AI) has long been touted as a game changer for pharma, so why are there so few examples of AI-driven drugs on the market?
In this webinar, we’ll explore the structural roadblocks that are impeding drug discovery programs, and discuss how FAIR data principles and open standards can accelerate speed to market and enable enterprise-wise digital transformation. In addition, we will consider pragmatic steps your lab can take today to harmonize your data inputs and automate data capture.